LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network

Y Wang, Z Qi, Z Li, S Bai, A Damirin - Journal of Cancer Research and …, 2023 - Springer
Purpose Lysophosphatidic acid (LPA) exerts various physiological and pathological effects
by activating its distinct G-protein-coupled LPA receptors. We demonstrated that LPA can …

LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma

K Sun, R Chen, J Li, Z Luo - Hereditas, 2022 - Springer
Background Lysophosphatidic acid (LPA) and its receptors play a key role in regulating
cancer progression. Upregulation of LPA receptor 2 (LPAR2) plays a role in carcinogenesis; …

LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer

P Zhao, Q Yun, A Li, R Li, Y Yan, Y Wang, H Sun… - Medical Oncology, 2022 - Springer
Current studies have demonstrated that significant increased LPA levels to be observed in
ascites in patients with ovarian cancer. Although several studies have shown that …

[HTML][HTML] Lysophosphatidic acid receptor 6 (LPAR6) is a potential biomarker associated with lung adenocarcinoma

J He, R Gao, M Meng, M Yu, C Liu, J Li, Y Song… - International Journal of …, 2021 - mdpi.com
LPAR6 is the most recently determined G-protein-coupled receptor of the lysophosphatidic
acid receptor, and very few of studies have demonstrated the performance of LPAR6 in …

Paradoxical downregulation of LPAR3 exerts tumor-promoting activity through autophagy induction in Ras-transformed cells

SH Hwang, HG Kim, M Lee - BMC cancer, 2022 - Springer
Background Lysophosphatidic acid receptor 3 (LPAR3) is coupled to G α i/o and G α 11/q
signaling. Previously, we reported that LPAR3 is highly methylated in carcinogen-induced …

Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells

PN Khoi, S Li, UT Thuan, DK Sah, TW Kang… - International Journal of …, 2020 - mdpi.com
Muscle invasive bladder carcinoma is a highly malignant cancer with a high mortality rate,
due to its tendency to metastasize. The tyrosine kinase recepteur d'origine nantais (RON) …

Lysophosphatidic acid receptor 6 (LPAR6) expression and prospective signaling pathway analysis in breast cancer

K Tao, S Guo, R Chen, C Yang, L Jian, H Yu… - Molecular Diagnosis & …, 2019 - Springer
Abstract Background and Objective Lysophosphatidic acid (LPA) has widely been reported
to participate in the numerous biological behaviors of tumors through its receptors. LPA …

Disruption of LPA‐LPAR1 pathway results in lung tumor growth inhibition by downregulating B7‐H3 expression in fibroblasts

F Meng, Z Yin, F Lu, W Wang, H Zhang - Thoracic Cancer, 2024 - Wiley Online Library
Abstract Background Lysophosphatidic acids (LPAs) belong to a class of bioactive
lysophospholipids with multiple functions including immunomodulatory roles in tumor …

LPAR1, correlated with immune infiltrates, is a potential prognostic biomarker in prostate cancer

J Shi, D Jiang, S Yang, X Zhang, J Wang, Y Liu… - Frontiers in …, 2020 - frontiersin.org
Prostate cancer is a common malignancy in men worldwide. Lysophosphatidic acid receptor
1 (LPAR1) is a critical gene and it mediates diverse biologic functions in tumor. However, the …

Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells

S Ishii, M Hirane, K Fukushima, A Tomimatsu… - Biochemical and …, 2015 - Elsevier
Lysophosphatidic acid (LPA) is an extracellular biological lipid which interacts with G protein-
coupled LPA receptors (LPA 1 to LPA 6). LPA signaling via LPA receptors mediates several …